NFE2L2 and cancer: In fact, sustained Nrf2 activity in cancer leads to resistance to chemo- and radiotherapy, and it is linked to a poor prognosis, making necessary the development of approaches to restrict Nrf2 activity and downstream effects and thus representing a promising target for the treatment of tumors [28].